ImmProNano Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
ImmProNano General Information
Description
Operator of research organization, utilizing state of the art mass-spectrometry to determine major histocompatibility complex expression libraries of virally infected cells. The company offers to deliver solutions and services to its clients for complex immunological, proteomic and nanoformulation problems by applying innovative approaches to scientific problems with the degree of care.
Contact Information
Website
www.immpronano.comCorporate Office
- 3805 Old Easton Road
- Doylestown, PA
- United States
Corporate Office
- 3805 Old Easton Road
- Doylestown, PA
- United States
ImmProNano Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ImmProNano FAQs
-
When was ImmProNano founded?
ImmProNano was founded in 2015.
-
Where is ImmProNano headquartered?
ImmProNano is headquartered in Doylestown, PA.
-
What industry is ImmProNano in?
ImmProNano’s primary industry is Drug Discovery.
-
Is ImmProNano a private or public company?
ImmProNano is a Private company.
-
What is ImmProNano’s current revenue?
The current revenue for ImmProNano is .
-
When was ImmProNano acquired?
ImmProNano was acquired on 01-Sep-2020.
-
Who acquired ImmProNano?
ImmProNano was acquired by Gylden Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process